17 alpha-hydroxyprogesterone caproate has been researched along with Abruptio Placentae in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, W; Biggio, J; Bukowski, R; Esplin, MS; Huang, H; Ilekis, J; Manuck, TA; Parry, S; Reddy, UM; Saade, G; Sadovsky, Y; Varner, MW; Zhang, H | 1 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Abruptio Placentae
Article | Year |
---|---|
Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Abruptio Placentae; Adult; Estrogen Antagonists; Female; Gestational Age; Humans; Hydroxyprogesterones; Longitudinal Studies; Pregnancy; Pregnancy, High-Risk; Premature Birth; Prospective Studies; Recurrence; Risk Factors; Treatment Failure; Uterine Hemorrhage; Young Adult | 2016 |